Cargando…
Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis
ANCA-associated vasculitides (AAV) are rare autoimmune diseases causing inflammation and damage to small blood vessels. New autoantibody biomarkers are needed to improve the diagnosis and treatment of AAV patients. In this study, we aimed to profile the autoantibody repertoire of AAV patients using...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607136/ https://www.ncbi.nlm.nih.gov/pubmed/37895021 http://dx.doi.org/10.3390/ijms242015341 |
_version_ | 1785127475174440960 |
---|---|
author | Mescia, Federica Bayati, Shaghayegh Brouwer, Elisabeth Heeringa, Peter Toonen, Erik J. M. Beenes, Marijke Ball, Miriam J. Rees, Andrew J. Kain, Renate Lyons, Paul A. Nilsson, Peter Pin, Elisa |
author_facet | Mescia, Federica Bayati, Shaghayegh Brouwer, Elisabeth Heeringa, Peter Toonen, Erik J. M. Beenes, Marijke Ball, Miriam J. Rees, Andrew J. Kain, Renate Lyons, Paul A. Nilsson, Peter Pin, Elisa |
author_sort | Mescia, Federica |
collection | PubMed |
description | ANCA-associated vasculitides (AAV) are rare autoimmune diseases causing inflammation and damage to small blood vessels. New autoantibody biomarkers are needed to improve the diagnosis and treatment of AAV patients. In this study, we aimed to profile the autoantibody repertoire of AAV patients using in-house developed antigen arrays to identify previously unreported antibodies linked to the disease per se, clinical subgroups, or clinical activity. A total of 1743 protein fragments representing 1561 unique proteins were screened in 229 serum samples collected from 137 AAV patients at presentation, remission, and relapse. Additionally, serum samples from healthy individuals and patients with other type of vasculitis and autoimmune-inflammatory conditions were included to evaluate the specificity of the autoantibodies identified in AAV. Autoreactivity against members of the kinesin protein family were identified in AAV patients, healthy volunteers, and disease controls. Anti-KIF4A antibodies were significantly more prevalent in AAV. We also observed possible associations between anti-kinesin antibodies and clinically relevant features within AAV patients. Further verification studies will be needed to confirm these findings. |
format | Online Article Text |
id | pubmed-10607136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106071362023-10-28 Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis Mescia, Federica Bayati, Shaghayegh Brouwer, Elisabeth Heeringa, Peter Toonen, Erik J. M. Beenes, Marijke Ball, Miriam J. Rees, Andrew J. Kain, Renate Lyons, Paul A. Nilsson, Peter Pin, Elisa Int J Mol Sci Article ANCA-associated vasculitides (AAV) are rare autoimmune diseases causing inflammation and damage to small blood vessels. New autoantibody biomarkers are needed to improve the diagnosis and treatment of AAV patients. In this study, we aimed to profile the autoantibody repertoire of AAV patients using in-house developed antigen arrays to identify previously unreported antibodies linked to the disease per se, clinical subgroups, or clinical activity. A total of 1743 protein fragments representing 1561 unique proteins were screened in 229 serum samples collected from 137 AAV patients at presentation, remission, and relapse. Additionally, serum samples from healthy individuals and patients with other type of vasculitis and autoimmune-inflammatory conditions were included to evaluate the specificity of the autoantibodies identified in AAV. Autoreactivity against members of the kinesin protein family were identified in AAV patients, healthy volunteers, and disease controls. Anti-KIF4A antibodies were significantly more prevalent in AAV. We also observed possible associations between anti-kinesin antibodies and clinically relevant features within AAV patients. Further verification studies will be needed to confirm these findings. MDPI 2023-10-19 /pmc/articles/PMC10607136/ /pubmed/37895021 http://dx.doi.org/10.3390/ijms242015341 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mescia, Federica Bayati, Shaghayegh Brouwer, Elisabeth Heeringa, Peter Toonen, Erik J. M. Beenes, Marijke Ball, Miriam J. Rees, Andrew J. Kain, Renate Lyons, Paul A. Nilsson, Peter Pin, Elisa Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis |
title | Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis |
title_full | Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis |
title_fullStr | Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis |
title_full_unstemmed | Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis |
title_short | Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis |
title_sort | autoantibody profiling and anti-kinesin reactivity in anca-associated vasculitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607136/ https://www.ncbi.nlm.nih.gov/pubmed/37895021 http://dx.doi.org/10.3390/ijms242015341 |
work_keys_str_mv | AT mesciafederica autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT bayatishaghayegh autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT brouwerelisabeth autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT heeringapeter autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT toonenerikjm autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT beenesmarijke autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT ballmiriamj autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT reesandrewj autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT kainrenate autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT lyonspaula autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT nilssonpeter autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis AT pinelisa autoantibodyprofilingandantikinesinreactivityinancaassociatedvasculitis |